Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05010512 · ClinicalTrials.gov registry record · NA

Clinical Performance of Two Commercial, Daily Disposable Contact Lenses

A NA study of Myopia and Refractive Errors, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
112
Enrollment target
8
Study locations

NCT05010512 is a NA study of Myopia and Refractive Errors that has completed, run by Alcon Research. The registered enrollment target is 112 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (58% lower). The trial reports 8 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05010512, a NA study of Myopia and Refractive Errors, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to compare the clinical performance of DAILIES TOTAL1 ( DT1) contact lenses with Infuse contact lenses.

Interventions

  • DEVICE Delefilcon A contact lenses
  • DEVICE Kalifilcon A contact lenses

Study Locations (8)

Florida

  • Alcon Investigator 6355 - Orlando
  • Alcon Investigator 6418 - Tallahassee

Illinois

  • Alcon Investigator 3950 - Bloomington
  • Alcon Investigator 6614 - Franklin Park

Tennessee

  • Alcon Investigator 6353 - Memphis
  • Alcon Investigator 2786 - Memphis

Minnesota

  • Alcon Investigator 6583 - Eden Prairie

Pennsylvania

  • Alcon Investigator 3382 - Wyomissing

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2021-08-31
Est. Completion 2021-10-12
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT05010512

The ClinicalTrials.gov registry entry for NCT05010512 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (58% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Delefilcon A contact lenses is the first listed.

NCT05010512 reports 8 study locations spanning 5 distinct geographic areas - top geographies include Florida, Illinois, Tennessee.

Frequently Asked Questions

What is clinical trial NCT05010512 about?

NCT05010512 is a clinical study titled "Clinical Performance of Two Commercial, Daily Disposable Contact Lenses". The purpose of this study is to compare the clinical performance of DAILIES TOTAL1 ( DT1) contact lenses with Infuse contact lenses.

What is the current status of trial NCT05010512?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2021-08-31. Estimated completion is 2021-10-12.

What conditions does trial NCT05010512 study?

This clinical trial studies the following conditions: Myopia, Refractive Errors, Ametropia.

What interventions are being tested in trial NCT05010512?

The interventions under investigation include: Delefilcon A contact lenses (DEVICE), Kalifilcon A contact lenses (DEVICE).

Who is sponsoring clinical trial NCT05010512?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05010512 being conducted?

This trial has 8 study locations across Florida, Illinois, Minnesota, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.